Имипенем/Циластатин Аптафарма

Имипенем/Циластатин Аптафарма is a fixed-dose combination antibiotic for intravenous use, combining imipenem and cilastatin. It is used to treat a wide range of bacterial infections by inhibiting bacterial cell wall synthesis. This EU-manufactured medication is designed for hospital and clinical settings.

Имипенем/Циластатин Аптафарма is used to treat serious bacterial infections such as pneumonia, urinary tract infections, intra-abdominal infections, and skin and soft tissue infections. It may also be prescribed for infections caused by bacteria resistant to other antibiotics. The combination works by preventing bacterial growth, making it effective against a broad spectrum of pathogens.

As an antibiotic, имипенем/циластатин апартафарма works by disrupting the formation of bacterial cell walls, which can lead to the breakdown of harmful bacteria. Patients may experience symptom relief as the infection clears, though individual responses vary. The medication is designed to target infections without affecting human cells in the same way.

This medication is administered intravenously and should only be handled by healthcare professionals. Patients with known allergies to carbapenem antibiotics or severe kidney disease may require adjusted dosing or alternative treatment. Always inform your healthcare provider about current medications and medical conditions before use.

Имипенем/Циластатин Аптафарма may interact with other medications, including certain anticonvulsants, blood thinners, and diuretics. Combining it with probenecid can increase imipenem levels in the blood. Alcohol and other drugs metabolized by the liver should be used cautiously, as interactions may affect efficacy or safety.